Qian Jiang

Dr. Qian Jiang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
YYYupeng Yang
Yupeng Yang
RQRuibin Qi
Ruibin Qi
MCMengru Chen
Mengru Chen
KFKexin Feng
Kexin Feng
ZLZhe Liu
Zhe Liu
JLJiasen Liu
Jiasen Liu
Background: Feline calicivirus (FCV), a pathogen that causes upper respiratory tract diseases in felids, primarily leads to oral ulcers and various respiratory symptoms, which can be fatal in severe cases. Currently, FCV prevention and control rely primarily on vaccination; however, the existing vaccine types in China are mainly inactivated vaccines, leading to a single prevention and control method with suboptimal outcomes. Methods and Results: This study commences with a genetic evolution analysis of Chinese FCV isolates, confirming the presence of two major genotypes, GI and GII with GI emerging as the dominant form. We subsequently selected the broadly neutralizing vaccine candidate strain DL39 as the template for the truncation and expression of multiple recombinant proteins. Through serological assays, we successfully confirmed the optimal protective antigen region, which is designated CE39 (CDE). Further investigation revealed the location of the optimal protective antigen region within the CE region for both the GI and GII genotype strains. Capitalizing on this discovery, a bivalent recombinant protein, designated CE39-CEFB, was generated. Cat antisera generated against CE39 and CE39-CEFB proteins were used in cross-neutralization against various strains of different genotypes, yielding high neutralization titers ranging from 1:45 to 1:15 and from 1:48 to 1:29, respectively, which surpassed those induced by antisera from cats vaccinated with Mi-aosanduo (commercial vaccine, strain 255). Ultimately, in vivo challenge experiments were per-formed after immunizing cats with the CE39 and CE39-CEFB proteins, utilizing Miaosanduo as a control for comparison. The results demonstrated that immunization with both proteins effectively made cats less susceptible to FCV GI, GII, and VSD strains infection, resulting in superior immune efficacy compared with that in the Miaosanduo group. Conclusion: These results indicate that this study successfully identified the antigen CE39, which has broad-spectrum antigenicity, through in vivo and in vitro experiments. These findings pre-liminarily demonstrate that the optimal protective antigen region of FCV strains is the CE region, laying a theoretical foundation for the development of novel broad-spectrum vaccines against FCV disease.

14 February 2025 in Applied Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
ZLZhe Liu
Zhe Liu
QJQian Jiang
Qian Jiang
YYYupeng Yang
Yupeng Yang
RQRuibin Qi
Ruibin Qi
HGHaorong Gu
Haorong Gu
JLJiasen Liu
Jiasen Liu
A comparative genomic analysis of feline coronavirus (FCoV) and feline panleukopenia virus (FPLV) was performed. Based on the conserved regions of the two

7 January 2022 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
YXYu-Jia Xue
Yu-Jia Xue
SCSai-Sai Cui
Sai-Sai Cui
DGDong-Chun Guo
Dong-Chun Guo
JLJia-Sen Liu
Jia-Sen Liu
MYMing-Fa Yang
Ming-Fa Yang
LQLian-Dong Qu
Lian-Dong Qu

2 January 2026 in Veterinary Microbiology
Verified
Journal Article
Closed access
CLChenchen Lu
Chenchen Lu
CZChenglan Zhang
Chenglan Zhang
YLYanan Li
Yanan Li
ZQZujian Qiao
Zujian Qiao
XWXijun Wang
Xijun Wang
SHSen Hu
Sen Hu

18 June 2026 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
LZLin Zhao
Lin Zhao
JFJiawen Fu
Jiawen Fu
SPSwaroop Peddiraju
Swaroop Peddiraju
HCHeming Chen
Heming Chen
KHKeqin Huang
Keqin Huang
HJHongLin Jia
HongLin Jia
All alveolates including apicomplexan parasites contain an inner membrane complex (IMC) underneath the plasma membrane. The IMC is synthesized de novo during asexual replication (including endodyogeny, endopolygeny, and schizogony) and serves as a crucial scaffold for supporting cytoskeletal structures and the glideosome machinery for parasite locomotion. However, the mechanism(s) underlying the membrane biogenesis in the IMC are not well understood. Using a clinically-relevant and globally-prevalent pathogenic protist model, Toxoplasma gondii , we identified the TgVPS13A bridging the IMC to the endoplasmic reticulum (ER) – the major site of phospholipid synthesis. The multi-modular TgVPS13A plays a crucial role in the IMC biogenesis, functioning in concert with an ER-resident VAP protein (TgVAP) and a novel lipid scramblase (TgDAT1). TgDAT1 is recruited for the progeny formation sites during the early stages of budding. Conditional depletion of TgVPS13A, TgDAT1 or TgVAP results in collapse of the inner membrane complex, leading to parasite death, as visualized by endodyogeny-specific organelle markers. GFP-Lact-C2, a biosensor of phosphatidylserine and phosphatidylthreonine lipids made in the ER and enriched in the IMC, also mislocalizes upon protein depletion. In conclusion, we propose that TgVPS13A, together with TgVAP and TgDAT1, bridge the ER and IMC and mediate the inter-organelle transport of lipids, thus contributing to the organelle biogenesis and daughter budding in T. gondii.

1 April 2026 in Virologica Sinica
Verified
Journal Article
Open access
DZDan Zang
Dan Zang
WHWuchang Heng
Wuchang Heng
RLRuiyu Li
Ruiyu Li
CWChenxi Wei
Chenxi Wei
RQRuibin Qi
Ruibin Qi
HKHongTao Kang
HongTao Kang
• An FCV-VP1 mRNA-LNP vaccine was constructed, utilizing a safe, flexible non-viral platform. • The vaccine elicits effective, durable neutralizing antibodies, protecting cats from FCV challenge. • This mRNA vaccine provided complete protection in cats, offering a novel effective strategy against FCV infection.